Improving end-of-life care for head and neck cancer patients

Expert Review of Anticancer Therapy

Volumn 12, Issue 3, 2012, Pages 335-343

  Shuman, Andrew G ^a,b   Fins, Joseph J ^a,b   Prince, Mark E ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

airway management; end of life; head and neck cancer; palliative care

Indexed keywords

METRONIDAZOLE;

ARTERY RUPTURE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL DECISION MAKING; COGNITIVE THERAPY; DEPRESSION; DYING; FAMILY COUNSELING; HEAD AND NECK CANCER; HUMAN; LARYNGECTOMY; LIFE EXPECTANCY; NONHUMAN; PATIENT CARE; PATIENT COUNSELING; PERSONAL EXPERIENCE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; SUPPORT GROUP; TERMINAL CARE; TERMINALLY ILL PATIENT; THYROIDECTOMY; TRACHEOTOMY;

BEHAVIOR CONTROL; BEHAVIORAL SYMPTOMS; HEAD AND NECK NEOPLASMS; HUMANS; PALLIATIVE CARE; PATIENT CARE MANAGEMENT; PROFESSIONAL-PATIENT RELATIONS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; TERMINAL CARE; TERMINALLY ILL; UNCERTAINTY;

EID: 84857861963     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.12.6     Document Type: Review

References (96)

1. Freud S, Molnar M; Freud Museum (London England). The Diary of Sigmund Freud, 1929-1939: A Record of the Final Decade. Scribner's, NY, USA (1992).
2. Tainmont J. Sigmund Freud's physicians and 'the monster'. B-ENT 3(1), 49-60 (2007).
3. Romm S. The oral cancer of Sigmund Freud. Clin. Plast. Surg. 10(4), 709-714 (1983).
4. Wang SJ, Wissel AR, Ord CB et al. Individualized estimation of conditional survival for patients with head and neck cancer. Otolaryngol. Head Neck Surg. 145(1), 71-73 (2011).
5. Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ 341, c4863 (2010).
6. Sciubba JJ. End of life considerations in the head and neck cancer patient. Oral Oncol. 45(4-5), 431-434 (2009).
7. Callahan C. Facial disfigurement and sense of self in head and neck cancer. Soc. Work Health Care 40(2), 73-87 (2004).
8. Lebel S, Castonguay M, Mackness G, Irish J, Bezjak A, Devins GM. The psychosocial impact of stigma in people with head and neck or lung cancer. Psychooncology doi:10.1002/pon.2063 (2011) (Epub ahead of print).
9. Adderley U, Smith R. Topical agents and dressings for fungating wounds. Cochrane Database Syst. Rev. 2, CD003948 (2007).
10. Shuman AG, Yang Y, Taylor JM, Prince ME. End-of-life care among head and neck cancer patients. Otolaryngol. Head Neck Surg. 144(5), 733-739 (2011).
11. Qaseem A, Snow V, Shekelle P et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: A clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 148(2), 141-146 (2008).
12. Forbes K. Palliative care in patients with cancer of the head and neck. Clin. Otolaryngol. Allied Sci. 22(2), 117-122 (1997).
13. American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: An updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 98(5), 1269-1277 (2003).
14. Shaha AR. Airway management in anaplastic thyroid carcinoma. Laryngoscope 118(7), 1195-1198 (2008).
15. Lin YL, Lin IC, Liou JC. Symptom patterns of patients with head and neck cancer in a palliative care unit. J. Palliat. Med. 14(5), 556-559 (2011).
16. Kowalski LP, Rinaldo A, Robbins KT et al. Stomal recurrence: Pathophysiology, treatment and prevention. Acta Otolaryngol. 123(3), 421-432 (2003).
17. Koutsimpelas D, Pitton M, Kulkens C, Lippert BM, Mann WJ. Endovascular carotid reconstruction in palliative head and neck cancer patients with threatened carotid blowout presents a beneficial supportive care measure. J. Palliat. Med. 11(5), 784-789 (2008).
18. Chang FC, Lirng JF, Luo CB et al. Patients with head and neck cancers and associated postirradiated carotid blowout syndrome: Endovascular therapeutic methods and outcomes. J. Vasc. Surg. 47(5), 936-945 (2008).
19. Cohen J, Rad I. Contemporary management of carotid blowout. Curr. Opin. Otolaryngol. Head Neck Surg. 12(2), 110-115 (2004).
20. Terrell JE, Ronis DL, Fowler KE et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130(4), 401-408 (2004).
21. Hardy JR, Rees E, Ling J et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat. Med. 15(1), 3-8 (2001).
22. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 272(16), 1263-1266 (1994).
23. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284(19), 2476-2482 (2000).
24. Sollner W, DeVries A, Steixner E et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br. J. Cancer 84(2), 179-185 (2001).
25. Espinosa E, Gonzalez Baron M, Zamora P, Ordonez A, Arranz P. Doctors also suffer when giving bad news to cancer patients. Support. Care Cancer 4(1), 61-63 (1996).
26. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300(14), 1665-1673 (2008).
27. Fins J. Truth telling and reciprocity in the doctor-patient relationship: A North American perspective. In:Topics in Palliative Care (Volume 5). RK Portenoy, Bruera E (Eds). Oxford University Press, Oxford, UK, 81-94 (2001).
28. Rogg L, Aasland OG, Graugaard PK, Loge JH. Direct communication, the unquestionable ideal? Oncologists' accounts of communication of bleak prognoses. Psychooncology 19(11), 1221-1228 (2010).
29. Silveira MJ, Kim SY, Langa KM. Advance directives and outcomes of surrogate decision making before death. N. Engl. J. Med. 362(13), 1211-1218 (2010).
30. Loprinzi CL, Johnson ME, Steer G. Doc, how much time do I have? J. Clin. Oncol. 18(3), 699-701 (2000).
31. Temel JS, Greer JA, Admane S et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: Results of a randomized study of early palliative care. J. Clin. Oncol. 29(17), 2319-2326 (2011).
32. Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J. Clin. 55(3), 164-177 (2005).
33. Adler NE, Page A; National Institue of Medicine (US). Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. National Academies Press, Washington DC, WA, USA (2008).
34. Steinhauser KE, Clipp EC, McNeilly M, Christakis NA, McIntyre LM, Tulsky JA. In search of a good death: Observations of patients, families, and providers. Ann. Intern. Med. 132(10), 825-832 (2000).
35. Duffy SA, Ronis DL, Valenstein M et al. Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 48(2), 142-148 (2007).
36. Lydiatt WM, Moran J, Burke WJ. A review of depression in the head and neck cancer patient. Clin. Adv. Hematol. Oncol. 7(6), 397-403 (2009).
37. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide in persons with cancer. J. Clin. Oncol. 26(29), 4731-4738 (2008).
38. Rayner L, Lee W, Price A et al. The clinical epidemiology of depression in palliative care and the predictive value of somatic symptoms: Cross-sectional survey with four-week follow-up. Palliat. Med. 25(3), 229-241 (2011).
39. Goodwin L, Lee W, Price A et al. Predictors of non-remission of depression in a palliative care population. Palliat. Med. doi:10.1177/ 0269216311412230 (2011) (Epub ahead of print).
40. Duffy SA, Ronis DL, Valenstein M et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev. 15(11), 2203-2208 (2006).
41. Lydiatt WM, Denman D, McNeilly DP, Puumula SE, Burke WJ. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 134(5), 528-535 (2008).
42. Semple CJ, Dunwoody L, Kernohan WG, McCaughan E. Development and evaluation of a problem-focused psychosocial intervention for patients with head and neck cancer. Support. Care Cancer 17(4), 379-388 (2009).
43. Shapiro PA, Kornfeld DS. Psychiatric aspects of head and neck cancer surgery. Psychiatr. Clin. North Am. 10(1), 87-100 (1987).
44. Johnson S, McDonald JT, Corsten M, Rourke R. Socio-economic status and head and neck cancer incidence in Canada: A case-control study. Oral Oncol. 46(3), 200-203 (2010).
45. Rao D, Debb S, Blitz D, Choi SW, Cella D. Racial/ethnic differences in the health-related quality of life of cancer patients. J. Pain Symptom Manage. 36(5), 488-496 (2008).
46. Simmons VN, Litvin EB, Patel RD et al. Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ. Couns. 77(3), 398-403 (2009).
47. Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF. Continued alcohol use in patients with head and neck cancer. Head Neck 32(7), 905-912 (2010).
48. Shuman AG, Wolf GT. Human papillomavirus status in head and neck cancer: The ethics of disclosure. Cancer 116(18), 4221-4226 (2010).
49. Foxwell KR, Scott SE. Coping together and apart: Exploring how patients and their caregivers manage terminal head and neck cancer. J. Psychosoc. Oncol. 29(3), 308-326 (2011).
50. Ma JL. Effect of perceived social support on adjustment of patients suffering from nasopharyngeal carcinoma. Health Soc. Work 23(3), 167-174 (1998).
51. Penner JL. Psychosocial care of patients with head and neck cancer. Semin. Oncol. Nurs. 25(3), 231-241 (2009).
52. Ross S, Mosher CE, Ronis-Tobin V, Hermele S, Ostroff JS. Psychosocial adjustment of family caregivers of head and neck cancer survivors. Support. Care Cancer 18(2), 171-178 (2010).
53. Ostroff J, Ross S, Steinglass P, Ronis-Tobin V, Singh B. Interest in and barriers to participation in multiple family groups among head and neck cancer survivors and their primary family caregivers. Fam. Process. 43(2), 195-208 (2004).
54. Hebert RS, Schulz R, Copeland VC, Arnold RM. Preparing family caregivers for death and bereavement. Insights from caregivers of terminally ill patients. J. Pain Symptom Manage. 37(1), 3-12 (2009).
55. Machiels JP, Schmitz S. Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck. Expert Rev. Anticancer Ther. 11(3), 359-371 (2011).
56. Tanvetyanon T, Padhya T, McCaffrey J et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J. Clin. Oncol. 27(12), 1983-1991 (2009).
57. McLarnon C, Kulloo P, Mehanna H, Kelly C, Paleri V. Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer. Expert Rev. Anticancer Ther. 10(3), 345-352 (2010).
58. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl. 93), 1-18 (2000).
59. Harrison LB, Raben A, Pfister DG et al. A prospective Phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck. Head Neck. 20(6), 497-503 (1998).
60. Chmura SJ, Milano MT, Haraf DJ. Reirradiation of recurrent head and neck cancers with curative intent. Semin. Oncol. 31(6), 816-821 (2004).
61. Mohanti BK, Umapathy H, Bahadur S, Thakar A, Pathy S. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother. Oncol. 71(3), 275-280 (2004).
62. Al-mamgani A, Tans L, Van rooij PH, Noever I, Baatenburg de jong RJ, Levendag PC. Hypofractionated radiotherapy denoted as the 'Christie scheme': An effective means of palliating patients with head and neck cancers not suitable for curative treatment. Acta. Oncol. 48(4), 562-570 (2009).
63. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: Is there a worthwhile quality of life gain? Cancer Treat. Rev. 37(7), 511-519 (2011).
64. De Crevoisier R, Bourhis J, Domenge C et al. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J. Clin. Oncol. 16(11), 3556-3562 (1998).
65. Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Reirradiation of recurrent and second primary head and neck malignancies: A comprehensive review. Cancer Treat. Rev. 29(1), 21-30 (2003).
66. Guntinas-Lichius O, Ruhlow S, Veelken F, Klussmann JP. Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxel. J. Cancer Res. Clin. Oncol. 135(7), 901-908 (2009).
67. Rivera F, Garcia-Castano A, Vega N, Vega-Villegas ME, Gutierrez-Sanz L. Cetuximab in metastatic or recurrent head and neck cancer: The EXTREME trial. Expert Rev. Anticancer Ther. 9(10), 1421-1428 (2009).
68. Spencer SA, Harris J, Wheeler RH et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 30(3), 281-288 (2008).
69. Jerjes W, Upile T, Akram S, Hopper C. The surgical palliation of advanced head and neck cancer using photodynamic therapy. Clin. Oncol. (R. Coll. Radiol.) 22(9), 785-791 (2010).
70. Owen RP, Khan SA, Negassa A et al. Radiofrequency ablation of advanced head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 137(5), 493-498 (2011).
71. Paleri V, Kelly CG. Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: A decision analysis model based on a systematic review. Clin. Otolaryngol. 33(4), 331-337 (2008).
72. Forastiere A, Goepfert H, Goffinet D et al. NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. Oncology (Williston Park) 12(7A), 39-147 (1998).
73. Daugherty C, Ratain MJ, Grochowski E et al. Perceptions of cancer patients and their physicians involved in Phase I trials. J. Clin. Oncol. 13(5), 1062-1072 (1995).
74. Jenkins V, Solis-Trapala I, Langridge C, Catt S, Talbot DC, Fallowfield LJ. What oncologists believe they said and what patients believe they heard: An analysis of Phase I trial discussions. J. Clin. Oncol. 29(1), 61-68 (2011).
75. Timon C, Reilly K. Head and neck mucosal squamous cell carcinoma: Results of palliative management. J. Laryngol. Otol. 120(5), 389-392 (2006).
76. Fins J. A Palliative Ethic of Care: Clinical Wisdom at Life's End. Jones and Bartlett, Sudbury, MA, USA (2006).
77. Casarett D, Pickard A, Bailey FA et al. Do palliative consultations improve patient outcomes? J. Am. Geriatr. Soc. 56(4), 593-599 (2008).
78. Goldstein NE, Genden E, Morrison RS. Palliative care for patients with head and neck cancer: "I would like a quick return to a normal lifestyle". JAMA 299(15), 1818-1825 (2008).
79. Talmi YP, Bercovici M, Waller A, Horowitz Z, Adunski A, Kronenberg J. Home and inpatient hospice care of terminal head and neck cancer patients. J. Palliat. Care 13(1), 9-14 (1997).
80. Sesterhenn AM, Folz BJ, Bieker M, Teymoortash A, Werner JA. End-of-life care for terminal head and neck cancer patients. Cancer Nurs. 31(2), E40-E46 (2008).
81. Daaleman TP, Usher BM, Williams SW, Rawlings J, Hanson LC. An exploratory study of spiritual care at the end of life. Ann. Fam. Med. 6(5), 406-411 (2008).
82. Potter J, Higginson IJ, Scadding JW, Quigley C. Identifying neuropathic pain in patients with head and neck cancer: Use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J. R. Soc. Med. 96(8), 379-383 (2003).
83. Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA. Quality of life scores predict survival among patients with head and neck cancer. J. Clin. Oncol. 26(16), 2754-2760 (2008).
84. Ferrell B, Levy MH, Paice J. Managing pain from advanced cancer in the palliative care setting. Clin. J. Oncol. Nurs. 12(4), 575-581 (2008).
85. Grond S, Zech D, Lynch J, Diefenbach C, Schug SA, Lehmann KA. Validation of World Health Organization guidelines for pain relief in head and neck cancer. A prospective study. Ann. Otol. Rhinol. Laryngol. 102(5), 342-348 (1993).
86. Quill TE, Byock IR. Responding to intractable terminal suffering: The role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann. Intern. Med. 132(5), 408-414 (2000).
87. Kissane DW. Freud's palliative care and natural death. Arch. Intern. Med. 160(1), 117; author reply 118 (2000).
88. Fins JJ. Affirming the right to care, preserving the right to die: Disorders of consciousness and neuroethics after Schiavo. Palliat. Support. Care 4(2), 169-178 (2000).
89. Temel JS, Greer JA, Muzikansky A et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N. Engl. J. Med. 363(8), 733-742 (2010).
90. Fins JJ, Schwager Guest R, Acres CA. Gaining insight into the care of hospitalized dying patients: An interpretative narrative analysis. J. Pain Symptom Manage. 20(6), 399-407 (2000).
91. Cranford RE. Medical futility: Transforming a clinical concept into legal and social policies. J. Am. Geriatr. Soc. 42(8), 894-898 (1994).
92. Ethunandan M, Rennie A, Hoffman G, Morey PJ, Brennan PA. Quality of dying in head and neck cancer patients: A retrospective analysis of potential indicators of care. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100(2), 147-152 (2005).
93. Ledeboer QC, Van der Velden LA, De Boer MF, Feenstra L, Pruyn JF. Palliative care for head and neck cancer patients in general practice. Acta. Otolaryngol. 126(9), 975-980 (2006).
94. Gould L, Lewis S. Care of head and neck cancer patients with swallowing difficulties. Br. J. Nurs. 15(20), 1091-1096 (2006).
95. Wheless SA, McKinney KA, Zanation AM. A prospective study of the clinical impact of a multidisciplinary head and neck tumor board. Otolaryngol. Head Neck Surg. 143(5), 650-654 (2010).
96. Finlay E, Shreve S, Casarett D. Nationwide veterans affairs quality measure for cancer: The family assessment of treatment at end of life. J. Clin. Oncol. 26(23), 3838-3844 (2008).